- Home
- BANR vs LKFT Comparison
BANR vs LKFT Comparison
Compare BANR & LKFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BANR | LKFT |
|---|---|---|
| Founded | 1890 | N/A |
| Country | United States | Belgium |
| Employees | N/A | 452 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.0B |
| IPO Year | 2015 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BANR | LKFT |
|---|---|---|
| Price | $70.29 | $27.84 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $70.00 | N/A |
| AVG Volume (30 Days) | ★ 424.7K | 148.2K |
| Earning Date | 04-22-2026 | N/A |
| Dividend Yield | ★ 3.14% | N/A |
| EPS Growth | ★ 15.57 | N/A |
| EPS | ★ 1.60 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.73 | N/A |
| Revenue Next Year | $5.69 | N/A |
| P/E Ratio | $43.03 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $57.05 | $27.97 |
| 52 Week High | $72.65 | $30.91 |
Technical Indicators
Market Signals| Indicator | BANR | LKFT |
|---|---|---|
| Relative Strength Index (RSI) | 57.62 | 37.08 |
| Support Level | $62.97 | N/A |
| Resistance Level | $72.65 | $30.25 |
| Average True Range (ATR) | 1.57 | 0.54 |
| MACD | -0.00 | -0.26 |
| Stochastic Oscillator | 60.71 | 1.96 |
Price Performance
Historical ComparisonAbout BANR Banner Corporation
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho, and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.
About LKFT Lakefront Biotherapeutics American Depositary Shares
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.